Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gordon Schanzlin New Vision Institute, formerly known as Gordon Binder Weiss Vision Institute, is a premier ophthalmology practice and clinical research center based in San Diego, California. Founded in 1993, the institute is recognized as a pioneer in refractive surgery, having performed the first LASIK procedure in San Diego. The practice offers a comprehensive range of advanced vision correction services, including LASIK, PRK, EVO ICL, and custom laser cataract surgery. Beyond clinical care, the institute is a prominent site for clinical trials, contributing to the development of new ophthalmic technologies and surgical techniques. It is currently part of the TLC Laser Eye Centers network and continues to lead in the implementation of innovative eye care solutions. The team consists of world-renowned surgeons who have contributed significantly to the field of refractive and corneal surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gordon Binder Weiss Vision Institute.